Product Information

MORPHINE SULFATE IR 30 MG TAB is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.3580 per EA under NDC 00054023624. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Mar 17, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MORPHINE SULFATE IR 30 MG TAB

Morphine Sulfate
$0.3580per EA
DEA Schedule CII

Strength

30 mg/1

NDC

00054023624

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

MORPHINE SULFATE

Approval Type

New Drug (NDA)

FDA Application

NDA022207

FDA Approved

3/17/2008

TE Code

AB

On Market Since

3/17/2008

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for MORPHINE SULFATE IR 30 MG TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 185.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3580 per EA
All-time high$0.6496 (May 15, 2019)
All-time low$0.1256 (Nov 28, 2013)
52-week high$0.4546
52-week low$0.3580
Median price$0.3840
Average price$0.3507
Largest weekly change+37.2% (May 18, 2016)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-9.1%

1M

-9.1%

3M

-10.7%

6M

-8.0%

1Y

-12.6%

3Y

-19.8%

5Y

-19.5%

All

+185.0%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of MORPHINE SULFATE IR 30 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE IR 30 MG TAB, manufactured by Hikma Pharmaceuticals USA Inc., is $0.3580 per EA (NDC 00054023624), effective Aug 19, 2026.

How has the price of MORPHINE SULFATE IR 30 MG TAB changed over time?

Over the history we have for it, the NADAC for MORPHINE SULFATE IR 30 MG TAB has risen 185.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE IR 30 MG TAB?

Since Nov 28, 2013, the NADAC for MORPHINE SULFATE IR 30 MG TAB has ranged from a low of $0.1256 (Nov 28, 2013) to a high of $0.6496 (May 15, 2019), with a median of $0.3840 per EA.

Are there cheaper alternatives to MORPHINE SULFATE IR 30 MG TAB?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MORPHINE SULF ER 30 MG TABLET, is $0.3462 per EA — about 3% below MORPHINE SULFATE IR 30 MG TAB.

Who manufactures MORPHINE SULFATE IR 30 MG TAB?

MORPHINE SULFATE IR 30 MG TAB (NDC 00054023624) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.